Scholarlink

Objective <p>Age stratified data regarding symptomatic and survival outcome of patients undergoing transcatheter tricuspid valve edge-to-edge repair (T-TEER) for severe tricuspid regurgitation (TR) are scarce. Aim of this study was to evaluate TR reduction, symptomatic outcomes, and survival following T-TEER stratified by patient age at intervention.</p> Methods <p>Using data from the large European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR registry, NCT06307262) we investigated the impact of patient age at intervention on procedural TR reduction, clinical outcome according to New York Heart Association (NYHA) class at latest available follow-up and two-year survival as well as two-year survival free from hospitalization for heart failure (HHF).</p> Results <p>The study included 2340 patients divided into four groups according to quartiles of age at intervention (1st quartile: 668 patients [69.9 ± 7.2&#xa0;years] up to 4th quartile: 561 patients [86.2 ± 2.2&#xa0;years]). Most common TR etiology in all groups was secondary TR with 83.6%–90.1%. TR reduction from baseline to discharge was similar in all groups (TR ≤2+&#xa0;77.3% 1st quartile, 82% 2nd quartile, 79.5% 3rd quartile and 82.8% 4th quartile, p = 0.085). TR severity at follow-up was also comparable (TR ≤2+&#xa0;68.1% 1st quartile, 72.1% 2nd quartile, 76.7% 3rd quartile and 73.7% 4th quartile, p = 0.135). Regarding NYHA class patients in all groups benefited equally. Overall two-year survival and two-year survival free from HHF after intervention did not differ between age groups.</p> Conclusions <p>T-TEER effectively reduces TR in elderly patients. Irrespective of age, patients showed symptomatic benefit and comparable two-year survival free from HHF.</p> Graphical abstract <p>Impact of age on outcomes after T-TEER: T-TEER is associated with effective TR reduction and improvement in heart failure symptoms irrespective of patient age at intervention.</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of age on outcomes after transcatheter tricuspid valve edge-to-edge repair: insights from EuroTR

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月23日

查看全文
  • Julia Novotny,
  • Lukas Stolz,
  • Karl-Patrik Kresoja,
  • Jennifer von Stein,
  • Vera Fortmeier,
  • Christoph Pauschinger,
  • Wolfgang Rottbauer,
  • Mohammad Kassar,
  • Bjoern Goebel,
  • Paolo Denti,
  • Paul Achouh,
  • Tienush Rassaf,
  • Manuel Barreiro-Perez,
  • Peter Boekstegers,
  • Andreas Rück,
  • Monika Zdanyte,
  • Marianna Adamo,
  • Philipp M. Doldi,
  • Ludwig T. Weckbach,
  • Thomas J. Stocker,
  • Flavien Vincent,
  • Philipp Schlegel,
  • Sebastian Rosch,
  • Mirjam G. Wild,
  • Christian Besler,
  • Stefan Toggweiler,
  • Stephanie Brunner,
  • Julia Grapsa,
  • Tiffany Patterson,
  • Holger Thiele,
  • Tobias Kister,
  • Giuseppe Tarantini,
  • Giulia Masiero,
  • Marco De Carlo,
  • Alessandro Sticchi,
  • Fabian Voss,
  • Amin Polzin,
  • Antonio Popolo Rubbio,
  • Francesco Bedogni,
  • Mathias H. Konstandin,
  • Eric Van Belle,
  • Marco Metra,
  • Tobias Geisler,
  • Rodrigo Estévez-Loureiro,
  • Amir Abbas Mahabadi,
  • Nicole Karam,
  • Francesco Maisano,
  • Philipp Lauten,
  • Fabien Praz,
  • Mirjam Kessler,
  • Daniel Kalbacher,
  • Volker Rudolph,
  • Christos Iliadis,
  • Philipp Lurz,
  • Jörg Hausleiter,
  • Kaspar Volz,
  • Karl-Philip Rommel,
  • Ralph Stephan von Bardeleben,
  • Roman Pfister,
  • Stephan Baldus,
  • Philipp von Stein,
  • Muhammed Gerçek,
  • Felix Rudolph,
  • Sebastian Ludwig,
  • Benedikt Koell,
  • Leonhard-Moritz Schneider,
  • Dominik Felbel,
  • Carsten Salomon,
  • Harald Lapp,
  • Tania Puscas,
  • Alain Berrebi,
  • Florian Schindhelm,
  • Berenice Caneiro-Queija,
  • Julio Echarte-Morales,
  • Andreas Goldschmied,
  • Edoardo Pancaldi,
  • Elisa Pezzola,
  • Natacha Rousse,
  • Samy Aghezzaf,
  • Norbert Frey,
  • Martin Kraus,
  • Dirk Westermann,
  • Federico Arturi

摘要

Objective

Age stratified data regarding symptomatic and survival outcome of patients undergoing transcatheter tricuspid valve edge-to-edge repair (T-TEER) for severe tricuspid regurgitation (TR) are scarce. Aim of this study was to evaluate TR reduction, symptomatic outcomes, and survival following T-TEER stratified by patient age at intervention.

Methods

Using data from the large European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR registry, NCT06307262) we investigated the impact of patient age at intervention on procedural TR reduction, clinical outcome according to New York Heart Association (NYHA) class at latest available follow-up and two-year survival as well as two-year survival free from hospitalization for heart failure (HHF).

Results

The study included 2340 patients divided into four groups according to quartiles of age at intervention (1st quartile: 668 patients [69.9 ± 7.2 years] up to 4th quartile: 561 patients [86.2 ± 2.2 years]). Most common TR etiology in all groups was secondary TR with 83.6%–90.1%. TR reduction from baseline to discharge was similar in all groups (TR ≤2+ 77.3% 1st quartile, 82% 2nd quartile, 79.5% 3rd quartile and 82.8% 4th quartile, p = 0.085). TR severity at follow-up was also comparable (TR ≤2+ 68.1% 1st quartile, 72.1% 2nd quartile, 76.7% 3rd quartile and 73.7% 4th quartile, p = 0.135). Regarding NYHA class patients in all groups benefited equally. Overall two-year survival and two-year survival free from HHF after intervention did not differ between age groups.

Conclusions

T-TEER effectively reduces TR in elderly patients. Irrespective of age, patients showed symptomatic benefit and comparable two-year survival free from HHF.

Graphical abstract

Impact of age on outcomes after T-TEER: T-TEER is associated with effective TR reduction and improvement in heart failure symptoms irrespective of patient age at intervention.